Literature DB >> 9168176

Screening for CDKN2A mutations in hereditary melanoma.

A M Goldstein, M A Tucker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9168176     DOI： 10.1093/jnci/89.10.676

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Authors:  Nicholas J Taylor; Nandita Mitra; Lu Qian; Marie-Françoise Avril; D Timothy Bishop; Brigitte Bressac-de Paillerets; William Bruno; Donato Calista; Francisco Cuellar; Anne E Cust; Florence Demenais; David E Elder; Anne-Marie Gerdes; Paola Ghiorzo; Alisa M Goldstein; Thais C Grazziotin; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas K Hayward; Marko Hocevar; Veronica Höiom; Elizabeth A Holland; Christian Ingvar; Maria Teresa Landi; Gilles Landman; Alejandra Larre-Borges; Graham J Mann; Eduardo Nagore; Håkan Olsson; Jane M Palmer; Barbara Perić; Dace Pjanova; Antonia L Pritchard; Susana Puig; Helen Schmid; Nienke van der Stoep; Margaret A Tucker; Karin A W Wadt; Xiaohong R Yang; Julia A Newton-Bishop; Peter A Kanetsky
Journal:  J Am Acad Dermatol       Date:  2019-02-05       Impact factor: 11.527

2.  CDKN2A germline mutations in familial pancreatic cancer.

Authors:  Detlef K Bartsch; Mercedes Sina-Frey; Sven Lang; Anja Wild; Berthold Gerdes; Peter Barth; Ralf Kress; Robert Grützmann; Mario Colombo-Benkmann; Andreas Ziegler; Stephan A Hahn; Matthias Rothmund; Harald Rieder
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

3.  Novel presentation of a familial pancreatic cancer syndrome.

Authors:  Ajay V Maker; James A Warth; Michael J Zinner
Journal:  J Gastrointest Surg       Date:  2008-12-17       Impact factor: 3.452

Review 4.  Mechanisms and therapeutic implications of cellular senescence in osteoarthritis.

Authors:  Philip R Coryell; Brian O Diekman; Richard F Loeser
Journal:  Nat Rev Rheumatol       Date:  2020-11-18       Impact factor: 20.543

5.  The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4.

Authors:  Alisa M Goldstein; Margaret A Tucker; Michael R Sargen; Ruth M Pfeiffer; David E Elder; Xiaohong R Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04       Impact factor: 4.090

6.  Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Authors:  J A Newton Bishop; M Harland; D C Bennett; V Bataille; A M Goldstein; M A Tucker; B A Ponder; J Cuzick; P Selby; D T Bishop
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Screening of potential novel candidate genes in schwannomatosis patients.

Authors:  Cristina Perez-Becerril; Andrew J Wallace; Helene Schlecht; Naomi L Bowers; Philip T Smith; Carolyn Gokhale; Helen Eaton; Chris Charlton; Rachel Robinson; Ruth S Charlton; D Gareth Evans; Miriam J Smith
Journal:  Hum Mutat       Date:  2022-06-27       Impact factor: 4.700
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.